Uridine treatment normalizes the congenital dyserythropoietic anemia type II-like hematological phenotype in a patient with homozygous mutation in the CAD gene.

Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/29000

Title:	Uridine treatment normalizes the congenital dyserythropoietic anemia type II-like hematological phenotype in a patient with homozygous mutation in the CAD gene.
Authors:	Radhakrishnan K. ;Iolascon A.;Fahey M. ;Russo R.;Marra R.;Andolfo I.;Manna F.;De Rosa G.;Rosato B.E.
Institution:	(Russo, Marra, Andolfo, Rosato, Iolascon) Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita degli Studi di Napoli Federico II, Naples, Italy (Russo, Marra, Andolfo, Manna, De Rosa, Rosato, Iolascon) CEINGE Biotecnologie Avanzate, Naples, Italy (Radhakrishnan) Paediatric Haematology/Oncology, Children's Cancer Centre, Monash Children's Hospital, Melbourne, VIC, Australia (Radhakrishnan) Department of Haematology, Monash Medical Centre, Melbourne, VIC, Australia (Fahey) Department of Paediatrics, Monash University, Clayton, VIC, Australia
Issue Date:	21-Dec-2020
Copyright year:	2020
Publisher:	Wiley-Liss Inc.
Place of publication:	United States
Publication information:	American Journal of Hematology. 95 (11) (pp 1423-1426), 2020. Date of Publication: 01 Nov 2020.
Journal:	American Journal of Hematology
DOI:	http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1002/ajh.25946
PubMed URL:	32720728 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32720728]
ISSN:	0361-8609
URI:	https://repository.monashhealth.org/monashhealthjspui/handle/1/29000
Type:	Article
Type of Clinical Study or Trial:	Case series or case report
Appears in Collections:	Articles

36

checked on Feb 20, 2025

Check